EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Brain Characteristics in Patients With Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disorder by 7.0 Tesla MRI

Lei Su, Joseph Kuchling iD, Chenyang Gao, Thoralf Niendorf, Carsten Finke iD, Zhe Zhang, Ai Guo iD, Jing Jing iD, De-Cai Tian iD, Yu-Jing Li, Mengting Zhang, Xiaoyu Shi und 8 weitere

Annals of Clinical and Translational Neurology · 2025

DOI: 10.1002/acn3.70080 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Lei Su und 19 weiteren Autor:innen. Beteiligte Einrichtung: Tiantan Neuroimaging Center of Excellence, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medic…. Hauptthemen laut MEDLINE: Myelin-Oligodendrocyte Glycoprotein, Magnetic Resonance Imaging, Demyelinating Autoimmune Diseases, CNS, Cerebral Cortex. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) can radiographically mimic multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). The disease hallmarks cortical lesion, central vein sign (CVS) and paramagnetic rim lesions identified in MS have not yet been comprehensively investigated in MOGAD.

Methods

We have characterized 45 patients with MOGAD using 7.0 Tesla (7 T) MRI at two academic research hospitals in China and Germany. 7 T MRI, laboratory, and clinical data were collected. The classification of cortical lesions, proportion of CVS, and the phase shifts of lesions on susceptibility weighted imaging were analyzed.

Results

Of the 45 patients enrolled with MOGAD, 282 lesions were identified. We further detected 31 (11%) cortical lesions including leukocortical, intracortical, and subpial types, of which intracortical lesions (16/31, 52%) were frequently involved. CVS was identified in 53 (19%) lesions of 21 (47%) patients, 154 (55%) lesions showed multiple veins sign (MVS) in 30 (67%) patients. The number (4.3 ± 6.0 vs. 1.5 ± 2.1, p = 0.0049) and percentage (52% vs. 18%, p < 0.0001) of MVS lesions for each MOGAD patient were higher than those of CVS. Eight patients (18%) had 39 (14%) lesions of hypointense signal with paramagnetic phase shifts on SWI, showing nodular phase changes and irregular borders in appearance.

Conclusions

In our observational MOGAD cohort, all three types of cortical lesions were recognized, with intracortical lesions being the most common. The number and proportion of lesions with MVS were higher than those with CVS. Lesions with paramagnetic phase changes were rare and non‐rim‐like in appearance. These findings provide a better understanding of the underlying pathology of MOGAD and will help in the differentiation of MOGAD from other demyelinating disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelin-Oligodendrocyte GlycoproteinMagnetic Resonance ImagingDemyelinating Autoimmune Diseases, CNSCerebral CortexBrainHumansFemaleMaleAdultMiddle AgedYoung AdultAutoantibodiesAdolescentAgedMultiple Sclerosis

Stichwörter der Autor:innen

7 T MRIcentral vein signcortical lesionmyelin oligodendrocyte glycoproteinparamagnetic rim lesion

Substanzen

Myelin-Oligodendrocyte GlycoproteinAutoantibodies

Autor:innen und Institutionen

  • Tiantan Neuroimaging Center of Excellence, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China.
  • Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Berlin Ultrahigh Field Facility, Max Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

ORCID-Profile: Joseph Kuchling, Carsten Finke, Ai Guo, Jing Jing, De-Cai Tian, Yaou Liu, Claudia Chien, Michael Levy, Friedemann Paul, Fu-Dong Shi

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Su, L., Kuchling, J., Gao, C., Niendorf, T., Finke, C., Zhang, Z., Guo, A., Jing, J., Tian, D. C., Li, Y. J., Zhang, M., Shi, X., Liu, X., Wang, H., Liu, Y., Chien, C., Levy, M., Duan, Y., Paul, F., & Shi, F. D. (2025). Brain Characteristics in Patients With Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disorder by 7.0 Tesla MRI. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70080

Vancouver

Su L, Kuchling J, Gao C, Niendorf T, Finke C, Zhang Z, et al. Brain Characteristics in Patients With Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disorder by 7.0 Tesla MRI. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70080

BibTeX
@article{Su2025,
  author = {Su, Lei and Kuchling, Joseph and Gao, Chenyang and Niendorf, Thoralf and Finke, Carsten and Zhang, Zhe and Guo, Ai and Jing, Jing and Tian, De-Cai and Li, Yu-Jing and Zhang, Mengting and Shi, Xiaoyu and Liu, Xinyao and Wang, Huabing and Liu, Yaou and Chien, Claudia and Levy, Michael and Duan, Yunyun and Paul, Friedemann and Shi, Fu-Dong},
  title = {Brain Characteristics in Patients With Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disorder by 7.0 Tesla MRI},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  doi = {10.1002/acn3.70080}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche